Stay updated on INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page.

Latest updates to the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFooter updates include adding 'Revision: v3.3.3' and removing 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. These changes are administrative and do not alter the study content or data presented on the page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedPage version updated from v3.2.0 to v3.3.2 with no visible changes to trial details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedA notice about government funding and NIH operations was removed from the page; the study details, eligibility criteria, and contacts remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedThe updates appear to be minor formatting adjustments and timestamp changes; core study content (eligibility criteria, outcomes, and intervention details) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check91 days agoChange DetectedCore content updated with a government operating-status notice and new version tag; a specific resource (Carcinoma of esophagus) was removed.SummaryDifference4%

- Check98 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0. No other content changes are indicated.SummaryDifference0.1%

Stay in the know with updates to INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page.